Aprogen Biologics Inc. (KRX:003060)
1,601.00
-1.00 (-0.06%)
Sep 22, 2026, 3:30 PM KST
| Market Cap | 22.97B -81.4% |
| Revenue (ttm) | 86.18B +26.1% |
| Net Income | -78.30B |
| EPS | -5,853.18 |
| Shares Out | 14.34M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 134,943 |
| Open | 1,625.00 |
| Previous Close | 1,602.00 |
| Day's Range | 1,591.00 - 1,625.00 |
| 52-Week Range | 1,580.00 - 9,945.00 |
| Beta | -0.21 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |